To evalutate the effect of Proniosome infused lidocaine and commercially available lidocaine gels for pain reduction during intraoral injections.
- Conditions
- Health Condition 1: K041- Necrosis of pulp
- Registration Number
- CTRI/2023/02/049535
- Lead Sponsor
- Dr Afreen Anjum S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Children of age group of 8-12 years.
2)Children requiring administration of buccal infiltration anesthesia irrespective of treatment.
3)Children with Franklâ??s behavior rating 3 and 4.
4)Children with good general health (ASA I).
5)Children who are willing to participate and whose parents give informed consent.
1)Medically compromised children.
2)Patient with history of anxiety disorder.
3)Children or parents not willing to participate.
4)Patients with history of allergy to local anesthesia.
5)Patients on medication that can alter pain perception.
6)Presence of lesion at the site of application.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare and evaluate the pain perception following topical application of proniosome infused lidocaine and commercially lidocaine gelsTimepoint: 5 minutes after application
- Secondary Outcome Measures
Name Time Method to evaluate for any adverse effects following topical application of comparator agentTimepoint: 5 minutes after application